1. Immunohistochemical detection of phosphorylated JAK-2 and STAT-5 proteins and correlation with erythropoietin receptor (EpoR) expression status in human brain tumors

   • M. Kondyli
   • G. Gatzounis
   • M. Assimakopoulou

   Laboratory Investigation - Human/Animal Tissue 25 March 2010 Pages: 157 - 164

   

2. IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines

   • Qinglin Liu
   • Gang Li
   • Jian Zhang

   Laboratory Investigation - Human/Animal Tissue 02 April 2010 Pages: 165 - 176

   

3. Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance

   • Gaspar J. Kitange
   • Brett L. Carlson
   • Jann N. Sarkaria

   Laboratory Investigation - Human/Animal Tissue 05 May 2010 Pages: 177 - 186

   

4. Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population

   • Delia Kurzwelly
   • Stefan Knop
   • Ulrich Herrlinger

   Clinical Study - Patient Study 17 March 2010 Pages: 187 - 192

5. A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study

   • Chae-Yong Kim
   • Seung-Ki Kim
   • Byung-Kyu Cho

   Clinical Study - Patient Study 23 March 2010 Pages: 193 - 198

   

6. Natural history and management of low-grade glioma in NF-1 children

   • Pablo Hernáiz Driever
   • Stephan von Hornstein
   • Astrid K. Gnekow

   Clinical Study - Patient Study 30 March 2010 Pages: 199 - 207

   

7. Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study

   • Alessandra Fabi
   • Giulio Metro
   • Andrea Pace

   Clinical Study - Patient Study 30 March 2010 Pages: 209 - 215

   

8. Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas

   • Kuan-Yin Tseng
   • Min-Huey Chung
   • Dueng-Yuan Hueng

   Clinical Study - Patient Study 29 April 2010 Pages: 217 - 223

   

9. Prognostic value of pretreatment ¹⁸F-FDG PET in patients with primary central nervous system lymphoma: SUV-based assessment

   • Nobuyuki Kawai
   • Hai-Ning Zhen
   • Takashi Tamiya

   Clinical Study - Patient Study 14 April 2010 Pages: 225 - 232

   

10. Inverse association of PPARγ agonists use and high grade glioma development

    • Christian Grommes
    • Devon S. Conway
    • Jill S. Barnholtz-Sloan

    Clinical Study - Patient Study 05 May 2010 Pages: 233 - 239

    

11. Phase I/II dose escalation trial of concurrent temozolomide and whole brain radiation therapy for multiple brain metastasis

    • Tom Mikkelsen
    • Joe Anderson
    • Lonni Schultz

    Clinical Study - Patient Study 30 April 2010 Pages: 241 - 247

12. Expression of signal transducer and activator of transcription 3 (STAT3) in primary central nervous system diffuse large B-cell lymphoma: a retrospective analysis of 17 cases

    • Neerja Vajpayee
    • Juhi Hussain
    • Ajeet Gajra

    Clinical Study – Patient Study 06 May 2010 Pages: 249 - 253

    

13. Factors influencing overall survival rates for patients with pineocytoma

    • Aaron J. Clark
    • Michael E. Sughrue
    • Andrew T. Parsa

    Clinical Study – Patient Study Open access 12 May 2010 Pages: 255 - 260

    

14. A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

    • David M. Peereboom
    • Jeffrey G. Supko
    • The New Approaches to Brain Tumor Therapy (NABTT) Consortium

    Clinical Study – Patient Study 07 May 2010 Pages: 261 - 268

15. Erratum to: A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

    • David M. Peereboom
    • Jeffrey G. Supko
    • The New Approaches to Brain Tumor Therapy (NABTT) Consortium

    Erratum 01 June 2010 Pages: 269 - 269

16. Epstein–Barr virus-associated primary central nervous system lymphomas in immunocompetent elderly patients: analysis for latent membrane protein-1 oncogene deletion and EBNA-2 strain typing

    • Yasuo Sugita
    • Mizuhiko Terasaki
    • Naoko Asano

    Clinical Study – Patient Study 09 May 2010 Pages: 271 - 279

    

17. Treatment-induced leukoencephalopathy in primary CNS lymphoma presenting as lower body parkinsonism

    • Antonio Milia
    • Giuseppina Pilia
    • Francesco Maria Manconi

    Case Report 30 March 2010 Pages: 281 - 283

    

18. Olfactory ensheathing cell tumour: case report and literature review

    • Ioana Darie
    • Laurent Riffaud
    • Abderrahmane Hamlat

    Case Report 08 April 2010 Pages: 285 - 289

    

19. Primary disseminated central neurocytoma: cytological and MRI evidence of tumor spread prior to surgery

    • Hoan Tran
    • Rafael Medina-Flores
    • Paul Turner

    Case Report 30 March 2010 Pages: 291 - 298

    

20. Radiation-induced cerebellar high-grade glioma accompanied by meningioma and cavernoma 29 years after the treatment of medulloblastoma: a case report

    • Tomoya Kamide
    • Mitsutoshi Nakada
    • Jun-ichiro Hamada

    Case Report 31 March 2010 Pages: 299 - 303

    

21. Meningeal chondroblastic osteosarcoma: case report and review of the literature

    • Emilie Romeo
    • Olivier Gisserot
    • François Bertucci

    Case Report 30 April 2010 Pages: 305 - 309

    

22. Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme?

    • Chiara Gallo
    • Carlo Buonerba
    • Alfredo Marinelli

    Case Report 17 June 2010 Pages: 311 - 319

    

23. Rapid recurrence of craniopharyngioma following recombinant human growth hormone replacement

    • Takafumi Taguchi
    • Toshihiro Takao
    • Yoshio Terada

    Letter to the Editor 28 March 2010 Pages: 321 - 322